Latest Stock Market News

Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya’s Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.

India is bracing for potential trade turmoil with the US as proposed 50% tariffs loom. Economist Swaminathan Aiyar suggests the dispute transcends trade, implicating geopolitics due to India s stance on Russian crude oil. Aiyar cautions about the impact on India s defense ties with the US, questioning future arms purchases if treated unfavorably.

India faces a major test as the US moves to impose 50% tariffs, shifting the issue from trade to geopolitics. While India explores diversification with Europe, ASEAN, and others, investor sentiment has weakened. Experts stress India’s strong fundamentals but caution that diplomatic strategy will be critical to safeguard growth.

Ashi Anand suggests a GST cut on farm equipment could boost India s rural economy. He believes large-scale tariffs on medicines are unlikely, despite US policy unpredictability. Investors should be selective in pharma, focusing on biosimilars and CRAMS. GLP therapies present a major opportunity as patents expire. CDMOs and branded generic players are well-positioned to capitalize on this trend.

Bitcoin slipped to $110,186, down over 4% in a week after Powell’s dovish Jackson Hole speech. Analysts warn of short-term downside pressures amid whale sell-offs and $550 million in liquidations, even as institutional flows and Ethereum’s strength underpin long-term bullish momentum in crypto markets.

Debt-free and low-leverage smallcaps are outperforming in FY26, with nine stocks delivering 70–135% returns. Two turned multibaggers, highlighting investor preference for financially disciplined companies amid market volatility.

HDFC Sec’s Varun Lohchab sees Indian markets delivering steady but modest returns, with earnings growth sustaining in double digits and consumption set to recover gradually aided by GST and tax reforms.

Gem Aromatics shares experienced a surge, reaching a day s high of Rs 349 on the BSE after a debut with a modest premium. The IPO, which was subscribed 30.45 times, saw significant interest from institutional and retail investors. Funds raised will be used to repay borrowings and for general corporate purposes.

Indian IT firms are unlikely to regain double-digit growth, with HSBC projecting long-term expansion of 4–5% due to structural headwinds, AI’s deflationary impact, and reliance on US/European demand.

Anondita Medicare s SME IPO witnessed substantial investor interest, oversubscribing 60.72 times, fueled by a strong grey market premium suggesting a potential 48% gain upon listing. The IPO aims to raise funds for capital expenditure, working capital, and potential acquisitions. The company, manufacturing condoms under the COBRA brand, has shown impressive revenue and profit growth.